These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24694254)

  • 1. Chronic lumbar intrathecal catheterization for the collection of cerebrospinal fluid in the canine.
    West W; Ehrmann J; Johnson W
    J Invest Surg; 2014 Aug; 27(4):226-33. PubMed ID: 24694254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.
    Lucey BP; Gonzales C; Das U; Li J; Siemers ER; Slemmon JR; Bateman RJ; Huang Y; Fox GB; Claassen JA; Slats D; Verbeek MM; Tong G; Soares H; Savage MJ; Kennedy M; Forman M; Sjögren M; Margolin R; Chen X; Farlow MR; Dean RA; Waring JF
    Alzheimers Res Ther; 2015; 7(1):53. PubMed ID: 26225140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors.
    Van Broeck B; Timmers M; Ramael S; Bogert J; Shaw LM; Mercken M; Slemmon J; Van Nueten L; Engelborghs S; Streffer JR
    Alzheimers Res Ther; 2016 May; 8(1):21. PubMed ID: 27206648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Invasive Lumbar Port System for the Collection of Cerebrospinal Fluid from Rhesus Macaques (Macaca mulatta).
    MacAllister RP; Lester McCully CM; Bacher J; Thomas ML; Cruz R; Wangari S; Warren KE
    Comp Med; 2016; 66(4):349-52. PubMed ID: 27538866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    Edsbagge M; Andreasson U; Ambarki K; Wikkelsø C; Eklund A; Blennow K; Zetterberg H; Tullberg M
    J Alzheimers Dis; 2017; 58(3):821-828. PubMed ID: 28505972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated lumbar punctures within 3 days may affect CSF biomarker levels.
    Olsson M; Ärlig J; Hedner J; Blennow K; Zetterberg H
    Fluids Barriers CNS; 2019 Dec; 16(1):37. PubMed ID: 31831030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continual cerebrospinal fluid sampling in the neonatal domestic piglet for biomarker and discovery studies.
    Pino MG; Ganguly R; Rich KA; Fox A; Mattox L; Keckley E; Joseph M; Malbrue R; Youngblood B; Krishna V; Kolb SJ
    J Neurosci Methods; 2022 Jan; 366():109403. PubMed ID: 34752813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile.
    den Daas I; Wemer J; Abou Farha K; Tamminga W; de Boer T; Spanjersberg R; Struys MM; Absalom AR
    Eur J Clin Pharmacol; 2013 May; 69(5):1083-90. PubMed ID: 23143156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.
    Pomeraniec IJ; Bond AE; Lopes MB; Jane JA
    J Neurosurg; 2016 Feb; 124(2):382-8. PubMed ID: 26339853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.
    Berger M; Nadler JW; Friedman A; McDonagh DL; Bennett ER; Cooter M; Qi W; Laskowitz DT; Ponnusamy V; Newman MF; Shaw LM; Warner DS; Mathew JP; James ML;
    J Alzheimers Dis; 2016 Apr; 52(4):1299-310. PubMed ID: 27079717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology.
    Rembach A; Evered LA; Li QX; Nash T; Vidaurre L; Fowler CJ; Pertile KK; Rumble RL; Trounson BO; Maher S; Mooney F; Farrow M; Taddei K; Rainey-Smith S; Laws SM; Macaulay SL; Wilson W; Darby DG; Martins RN; Ames D; Collins S; Silbert B; Masters CL; Doecke JD;
    Alzheimers Res Ther; 2015 Nov; 7(1):71. PubMed ID: 26581886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal stability of cerebrospinal fluid biomarker levels: fulfilled requirement for pharmacodynamic markers in Alzheimer's disease.
    Le Bastard N; Aerts L; Sleegers K; Martin JJ; Van Broeckhoven C; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2013; 33(3):807-22. PubMed ID: 23034521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid beta-amyloid and dynabridging in Alzheimer's disease drug development.
    Ereshefsky L; Jhee S; Yen M; Moran S; Pretorius S; Adams J
    Biomark Med; 2009 Dec; 3(6):711-21. PubMed ID: 20477709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.
    Fortea J; Vilaplana E; Alcolea D; Carmona-Iragui M; Sánchez-Saudinos MB; Sala I; Antón-Aguirre S; González S; Medrano S; Pegueroles J; Morenas E; Clarimón J; Blesa R; Lleó A;
    Ann Neurol; 2014 Aug; 76(2):223-30. PubMed ID: 24852682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical intrathecal catheter placement for cerebrospinal fluid drainage: technical case report.
    Wahlig JB; Welch WC; Kang JD; Jungreis CA
    Neurosurgery; 1999 Feb; 44(2):419-21. PubMed ID: 9932901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.